Hepatitis C virus infection is associated with the development of hepatocellular carcinoma (original) (raw)

Abstract

A possible causative role for the recently discovered hepatitis C virus (HCV) in the development of hepatocellular carcinoma (HCC) was investigated by assay of sera from HCC patients in Japan for antibodies to a recombinant HCV antigen and to hepatitis B virus (HBV) antigens. Among the 253 HCC patients examined, 156 (61.7%) had no serum markers of either a previous or a current HBV infection (group I), 46 (18.2%) were negative for HBV surface antigen but positive for anti-HBV surface and/or anti-HBV core antibody, indicating the occurrence of a previous, transient HBV infection (group II), and 51 (20.2%) were chronically infected HBV carriers as evidenced by positivity for HBV surface antigen (group III). The prevalence of HCV antibody in group I (68.6%) and II (58.7%) patients was significantly higher than for group III (3.9%) or in 148 additional patients with other (non-HCC) cancers (10.1%) (P less than 0.01). Thus, there appears to be a strong association between HCV infection and the development of HCC, particularly in patients for which HBV infection cannot be implicated as a causative factor. The data also suggest an additional mode of transmission for HCV other than blood transfusion, since a history of blood transfusion was shown in only about 30% of the HCV antibody-positive HCC patients in groups I and II. A high prevalence of HCV antibody was also shown among patients with HCC whose disease was originally thought to be due to very high ethanol consumption.

6547

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
  2. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  3. Dienstag J. L. non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology. 1983 Sep;85(3):743–768. [PubMed] [Google Scholar]
  4. Feinstone S. M., Kapikian A. Z., Purcell R. H., Alter H. J., Holland P. V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med. 1975 Apr 10;292(15):767–770. doi: 10.1056/NEJM197504102921502. [DOI] [PubMed] [Google Scholar]
  5. Kamitsukasa H., Harada H., Yakura M., Fukuda A., Ohbayashi A., Saito I., Miyamura T., Choo Q. L., Houghton M., Kuo G. Intrafamilial transmission of hepatitis C virus. Lancet. 1989 Oct 21;2(8669):987–987. doi: 10.1016/s0140-6736(89)91000-3. [DOI] [PubMed] [Google Scholar]
  6. Katayama T., Kikuchi S., Tanaka Y., Saito I., Miyamura T., Choo Q. L., Houghton M., Kuo G. Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion. 1990 May;30(4):374–376. doi: 10.1046/j.1537-2995.1990.30490273448.x. [DOI] [PubMed] [Google Scholar]
  7. Kiyosawa K., Akahane Y., Nagata A., Furuta S. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol. 1984 Oct;79(10):777–781. [PubMed] [Google Scholar]
  8. Knodell R. G., Conrad M. E., Ishak K. G. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology. 1977 May;72(5 Pt 1):902–909. [PubMed] [Google Scholar]
  9. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  10. Lefkowitch J. H., Apfelbaum T. F. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis. Arch Pathol Lab Med. 1987 Feb;111(2):170–173. [PubMed] [Google Scholar]
  11. Miyamura T., Saito I., Katayama T., Kikuchi S., Tateda A., Houghton M., Choo Q. L., Kuo G. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci U S A. 1990 Feb;87(3):983–987. doi: 10.1073/pnas.87.3.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mori W., Shah M. A comparative geo-pathological study of liver cirrhosis and primary hepatic cancer between Cambridge and Tokyo. Gan. 1972 Dec;63(6):765–771. [PubMed] [Google Scholar]
  13. Muchmore E., Popper H., Peterson D. A., Miller M. F., Lieberman H. M. Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol. 1988;17(5):235–246. [PubMed] [Google Scholar]
  14. Okuda H., Obata H., Motoike Y., Hisamitsu T. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients. Hepatogastroenterology. 1984 Apr;31(2):64–68. [PubMed] [Google Scholar]
  15. Prince A. M., Brotman B., Grady G. F., Kuhns W. J., Hazzi C., Levine R. W., Millian S. J. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 1974 Aug 3;2(7875):241–246. doi: 10.1016/s0140-6736(74)91412-3. [DOI] [PubMed] [Google Scholar]
  16. Rakela J., Redeker A. G. Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology. 1979 Dec;77(6):1200–1202. [PubMed] [Google Scholar]
  17. Realdi G., Alberti A., Rugge M., Rigoli A. M., Tremolada F., Schivazappa L., Ruol A. Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut. 1982 Apr;23(4):270–275. doi: 10.1136/gut.23.4.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Resnick R. H., Stone K., Antonioli D. Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. Dig Dis Sci. 1983 Oct;28(10):908–911. doi: 10.1007/BF01317042. [DOI] [PubMed] [Google Scholar]
  19. Sakamoto M., Hirohashi S., Tsuda H., Ino Y., Shimosato Y., Yamasaki S., Makuuchi M., Hasegawa H., Terada M., Hosoda Y. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res. 1988 Dec 15;48(24 Pt 1):7294–7297. [PubMed] [Google Scholar]
  20. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]
  21. Tateda A., Kikuchi K., Numazaki Y., Shirachi R., Ishida N. Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis. 1979 May;139(5):511–518. doi: 10.1093/infdis/139.5.511. [DOI] [PubMed] [Google Scholar]
  22. Yarrish R. L., Werner B. G., Blumberg B. S. Association of hepatitis B virus infection with hepatocellular carcinoma in American patients. Int J Cancer. 1980 Dec 15;26(6):711–715. doi: 10.1002/ijc.2910260603. [DOI] [PubMed] [Google Scholar]